Billing and Coding: MolDX: Repeat Germline Testing

This billing and coding article provides guidance that complements MolDX LCD L38351 and does not itself establish coverage criteria. Coverage of repeat germline testing is determined by the clinical and documentation requirements set forth in LCD L38351; claims must include prior test reports and clinical rationale and follow any payer-specific billing, coding, or prior authorization procedures.

"Repeat germline testing is covered when it meets the clinical and coverage criteria specified in the MolDX Local Coverage Determination L38351."

Sign up to see full coverage criteria, indications, and limitations.